[Normalizing effect of the pineal gland peptides on the daily melatonin rhythm in old monkeys and elderly people].
Level 4 - case-series / case-control
Uncontrolled interventional study/case series in animals and humans with no methodological or randomization details provided in the abstract
What was done
The study investigated the effects of pineal gland peptide preparations—Epithalamin (a complex of isolated pineal peptides) and Epitalon (a synthetic tetrapeptide)—on blood plasma melatonin concentrations and circadian rhythm parameters in aging monkeys and elderly humans. Specific administration protocols, dosing, control groups, and participant numbers were not reported in the abstract.
What was found
The abstract provides no numerical data, baseline values, or statistical metrics. It qualitatively reports that Epithalamin and Epitalon recovered nighttime endogenous melatonin release, restored hormone circadian rhythm amplitude in blood plasma, and increased nighttime melatonin in elderly individuals with pineal functional insufficiency without side effects.
Why it matters
If validated in rigorous trials, pineal peptide therapeutics could represent a method to restore endogenous melatonin rhythmicity and address age-related pineal dysfunction.
Limits
The abstract omits sample sizes, study design details, dosing regimens, treatment duration, and all quantitative data or statistical tests. The lack of reported control groups and blinding precludes independent evaluation of efficacy or bias.
Cited by
- supports Epithalamin administration upregulates melatonin synthesis enzymes and restores melatonin production in aged monkeys and humans.